These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26502743)

  • 1. Margaret McCartney: Flibanserin for low sexual desire is not feminism.
    McCartney M
    BMJ; 2015 Oct; 351():h5650. PubMed ID: 26502743
    [No Abstract]   [Full Text] [Related]  

  • 2. Flibanserin and Female Sexual Desire.
    Fantasia HC
    Nurs Womens Health; 2016; 20(3):309-14. PubMed ID: 27287358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flibanserin and its discontents.
    Aftab A; Chen C; McBride J
    Arch Womens Ment Health; 2017 Apr; 20(2):243-247. PubMed ID: 27858170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flibanserin for female sexual dysfunction.
    Reviriego C
    Drugs Today (Barc); 2014 Aug; 50(8):549-56. PubMed ID: 25187905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving prospects for treating hypoactive sexual desire disorder (HSDD): development status of flibanserin.
    Thorp J; Palacios S; Symons J; Simon J; Barbour K
    BJOG; 2014 Oct; 121(11):1328-31. PubMed ID: 24909923
    [No Abstract]   [Full Text] [Related]  

  • 6. [Flibanserin as pharmacological therapy of inhibited sexual desire in women].
    Eldon AS; Giraldi A
    Ugeskr Laeger; 2017 Feb; 179(7):. PubMed ID: 28397671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Circle of Female Sexual Desire-Have We Come a Long Way?
    Katz A
    Nurs Womens Health; 2016; 20(3):235-8. PubMed ID: 27287350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoactive sexual desire disorder: inventing a disease to sell low libido.
    Meixel A; Yanchar E; Fugh-Berman A
    J Med Ethics; 2015 Oct; 41(10):859-62. PubMed ID: 26124287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flibanserin (Addyi) for Hypoactive Sexual Desire Disorder in Premenopausal Women.
    Holt H; Tingen J
    Am Fam Physician; 2016 May; 93(10):826-8. PubMed ID: 27175717
    [No Abstract]   [Full Text] [Related]  

  • 10. US drug agency approves drug for low sexual desire in women.
    McCarthy M
    BMJ; 2015 Aug; 351():h4522. PubMed ID: 26292940
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of Flibanserin: Science and Advocacy at the FDA.
    Gellad WF; Flynn KE; Alexander GC
    JAMA; 2015 Sep; 314(9):869-70. PubMed ID: 26148201
    [No Abstract]   [Full Text] [Related]  

  • 12. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
    Goldfischer ER; Breaux J; Katz M; Kaufman J; Smith WB; Kimura T; Sand M; Pyke R
    J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women.
    Clayton AH; Dennerstein L; Pyke R; Sand M
    Womens Health (Lond); 2010 Sep; 6(5):639-53. PubMed ID: 20887163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA advisers to assess drug for low sexual desire in women.
    Moynihan R
    BMJ; 2010 May; 340():c2786. PubMed ID: 20501573
    [No Abstract]   [Full Text] [Related]  

  • 15. U.S. Food and Drug Administration Approval of Addyi (Flibanserin) for Treatment of Hypoactive Sexual Desire Disorder.
    Puppo G; Puppo V
    Eur Urol; 2016 Feb; 69(2):379-80. PubMed ID: 26455357
    [No Abstract]   [Full Text] [Related]  

  • 16. Flibanserin: First Global Approval.
    Deeks ED
    Drugs; 2015 Oct; 75(15):1815-22. PubMed ID: 26412054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flibanserin: From Bench to Bedside.
    Dooley EM; Miller MK; Clayton AH
    Sex Med Rev; 2017 Oct; 5(4):461-469. PubMed ID: 28757356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Flibanserin Meaningfully Superior to Placebo?
    Clayton AH; Pyke RE
    J Sex Marital Ther; 2017 Apr; 43(3):218-222. PubMed ID: 28075707
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA Approval of Flibanserin--Treating Hypoactive Sexual Desire Disorder.
    Joffe HV; Chang C; Sewell C; Easley O; Nguyen C; Dunn S; Lehrfeld K; Lee L; Kim MJ; Slagle AF; Beitz J
    N Engl J Med; 2016 Jan; 374(2):101-4. PubMed ID: 26649985
    [No Abstract]   [Full Text] [Related]  

  • 20. Evening the score on sex drugs: feminist movement or marketing masquerade?
    Moynihan R
    BMJ; 2014 Oct; 349():g6246. PubMed ID: 25354348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.